OPN protects dopaminergic cells from 1-methyl-4-phenylpyridinium toxicity and increases glial-derived neurotrophic factor and brain-derived neurotrophic factor levels, indicating that OPN is a double-edged sword in PD [115]. This evidence concerns the gene SPP1 and Parkinson disease.